Loading clinical trials...
Loading clinical trials...
Effects of Type A Botulinum Toxin in Obstructed Defecation Syndrome: a Phase II Randomized, Parallel-Group, Triple-Blind, Placebo-Controlled Trial
Conditions
Interventions
Botulinum Toxin-A
Normal Saline
Locations
1
United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Start Date
February 1, 2016
Primary Completion Date
June 11, 2019
Completion Date
June 11, 2019
Last Updated
May 12, 2020
Lead Sponsor
Massachusetts General Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions